Medicare Enrolled

Dr. Jeffrey Winston, MD

Psychiatry · Atlanta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4546 BARCLAY DR STE B, Atlanta, GA 30338
7704577994
In practice since 2007 (19 years)
NPI: 1003938598 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Winston from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Winston? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Winston

Dr. Jeffrey Winston is a psychiatry specialist in Atlanta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Winston performed 1,163 Medicare services across 325 unique beneficiaries.

Between the years covered by Open Payments, Dr. Winston received a total of $13,844 from 42 pharmaceutical and/or device companies across 735 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in psychiatry. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Winston is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 9% volume in GA $13,844 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,163
Medicare services
Top 9% in GA for psychiatry
325
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~61 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Psychotherapy and evaluation, 30 minutes
A combined session involving psychotherapy and an evaluation and management visit lasting 30 minutes.
466 $48 $100
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
422 $59 $152
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
259 $76 $185
Psychiatric diagnostic evaluation with medical services
A psychiatric assessment that includes medical services to evaluate mental health conditions.
16 $137 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,844
Total received (2018-2024)
Avg $1,978/year across 7 years
Top 7% in GA for psychiatry
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
735
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,844 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,751
2023
$2,936
2022
$2,017
2021
$1,725
2020
$1,263
2019
$1,602
2018
$1,549

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Supernus Pharmaceuticals, Inc.
$356
ABBVIE INC.
$230
Otsuka America Pharmaceutical, Inc.
$189
Tris Pharma Inc
$188
Alkermes, Inc.
$182
Axsome Therapeutics, Inc.
$182
Vanda Pharmaceuticals Inc.
$170
Janssen Pharmaceuticals, Inc
$169
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$167
Lundbeck LLC
$165
Bausch Health US, LLC
$156
Corium, LLC
$145
Neos Therapeutics, LP
$103
Takeda Pharmaceuticals U.S.A., Inc.
$102
IDORSIA PHARMACEUTICALS US INC
$61
Neurocrine Biosciences, Inc.
$58
Almatica Pharma LLC
$54
IRONSHORE PHARMACEUTICALS INC.
$34
Noven Therapeutics, LLC
$21
Brainsway USA INC
$18
Top 3 companies account for 28.2% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$1,754
Lundbeck LLC
$1,408
Takeda Pharmaceuticals U.S.A., Inc.
$1,158
Axsome Therapeutics, Inc.
$872
Neos Therapeutics, LP
$863
Supernus Pharmaceuticals, Inc.
$826
AbbVie Inc.
$673
Janssen Pharmaceuticals, Inc
$652
ITI, Inc.
$490
Tris Pharma Inc
$429
Shire North American Group Inc
$362
Allergan Inc.
$351
ABBVIE INC.
$350
Sunovion Pharmaceuticals Inc.
$314
Almatica Pharma LLC
$308
Corium, LLC
$308
Allergan, Inc.
$304
Vanda Pharmaceuticals Inc.
$281
Bausch Health US, LLC
$265
Alkermes, Inc.
$233
Teva Pharmaceuticals USA, Inc.
$216
Neurocrine Biosciences, Inc.
$210
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$167
Adlon Therapeutics L.P.
$124
IDORSIA PHARMACEUTICALS US INC
$120
LivaNova USA, Inc.
$112
Neuronetics, Inc.
$106
Ironshore Pharmaceuticals Inc.
$92
Merck Sharp & Dohme Corporation
$74
ARBOR PHARMACEUTICALS, INC.
$62
Otsuka Pharmaceutical Development & Commercialization, Inc.
$62
Alfasigma USA, Inc.
$38
Janssen Scientific Affairs, LLC
$36
Arbor Pharmaceuticals, Inc.
$35
IRONSHORE PHARMACEUTICALS INC.
$34
Brainsway USA INC
$33
Aytu BioPharma, Inc.
$32
Brainsway USA Inc
$26
Noven Therapeutics, LLC
$21
AYTU BioPharma, Inc.
$20
Orexo US, Inc.
$12
OWP Pharmaceuticals, Inc.
$12
Top 3 companies account for 31.2% of all-time payments
Associated products mentioned in payments ›
ABILIFY ASIMTUFII · ABILIFY MAINTENA · ADHANSIA XR · APLENZIN · ARISTADA · AUSTEDO · AZSTARYS · Adzenys XR-ODT · Austedo XR · Auvelity · Azstarys · BELSOMRA · BRINTELLIX · BrainsWay Deep TMS · Brainsway Deep TMS · Brainsway Deep TMS System · CAPLYTA · CITALOPRAM · COTEMPLA XR-ODT · Cotempla XR-ODT · Dyanavel XR · Evekeo · Evekeo ODT · FANAPT · Fanapt · Horizant · INGREZZA · INVEGA SUSTENNA · INVEGA TRINZA · JORNAY PM · Jornay PM 20mg capsules (Bottle of 100) · LATUDA · LOREEV XR · Lamotrigine Starter Kit · MYDAYIS · NEUROSTAR TMS THERAPY · QELBREE · QUVIVIQ · Qelbree · REXULTI · SERTRALINE HCL · SPRAVATO · TRINTELLIX · Trintellix · UZEDY · VIIBRYD · VNS THERAPY SYMMETRY MODEL 8103 GENERATOR · VRAYLAR · VYVANSE · WELLBUTRIN · WELLBUTRIN XL · Xelstrym · Zenzedi · Zubsolv
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for psychiatry in GA.

Looking for a psychiatry specialist in Atlanta?
Compare psychiatrists in the Atlanta area by procedure volume, costs, and industry payment transparency.
Browse psychiatrists nearby

Geographic Context

Psychiatrists within 10 mi
633
Per 100K population
83.1
County median income
$77,683
Nearest hospital
PEACHFORD BEHAVIORAL HEALTH SYSTEM OF ATLANTA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Winston is a clinical cardiology specialist, with above-average Medicare volume (top 9% in GA), with low-engagement industry engagement in the top 7% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Winston experienced with psychotherapy and evaluation, 30 minutes?
Based on Medicare claims data, Dr. Winston performed 466 psychotherapy and evaluation, 30 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Winston receive payments from pharmaceutical companies?
Yes. Dr. Winston received a total of $13,844 from 42 companies across 735 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Winston's costs compare to other psychiatrists in Atlanta?
Dr. Winston's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Winston) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →